baber/WOPTO huggingface dataset:
Patent NZ-574903-A (NZ)
Title: Louvre assembly with screw thread provided in louvre central bore for grub screw and spring loaded mounting pin
Inventor: JOLLY MICHAEL PETER
IPC: E04D13/17
Filed: 2007-07-16
Abstract: A louvre blade formed as an extrusion is described. The louvre blade includes front and rear curved faces joined at their ends to form an interior cavity and a support web located in the interior cavity between the front and rear faces and extending longitudinally along the louvre blade that defines a pivot axis. The support web also includes mounting means located on at least one end of the louvre blade to mount the louvre blade to be pivoted about the pivot axis. The mounting means has a bore extending longitudinally along the support web including a screw thread to receive a grub screw 240. This allows for a spring 241 and pin member 245 to be inserted at one, and typically each, end of the blade before end cap 250 is fastened to the louvre blade by screws 252 engaging part-circular grooves in the louvre blade which is typically extruded.
Patent NZ-576311-A (NZ)
Title: Antimicrobial composition comprising propiconazole and a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one
Inventor: ASHMORE JOHN WILLIAM
IPC: A01N33/04
Filed: 2006-06-08
Abstract: Disclosed is a synergistic antimicrobial composition which comprises: (a) propiconazole; and (b) a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one (CMI) and 2-methyl-4isothiazolin-3-one (MI). Also disclosed is a method of inhibiting the growth of microorganisms, the method comprising introducing an antimicrobially effective amount of a composition, as defined above, onto, into or at a locus subject to microbial attack. (62) Divided Out of 563783
Patent NZ-578227-A (NZ)
Title: Truncated parathyroid hormone peptides with a cyclic conformation for treating osteoporosis
Inventor: RYGE TRINE SKOVLUND
IPC: A61K38/29
Filed: 2007-12-06
Abstract: A parathyroid hormone PTH(1-17) analogue consisting of Formula III: R1-Ac5c-Val-Aib-Glu-Ile-A6-Leu-A8-His-A10-A11-Ala-A13-A14-Leu-A16-A17-R2 Wherein A6 is Glu or Gln; A8 is Met, Leu, Nle or Val; A10 is Gln or Glu; A11 is Har or Arg; A13 is Lys, Orn, Asp, Glu, Cys, Dab or Dpr; A14 is Trp or Phe; A16 is Asn or Asp; A17 is Lys, Orn, Glu, Cys, Asp, Dab or Dpr. Wherein there is a covalent linkage between A13 and A17. Or a parathyroid hormone PTH(1-17) analogue consisting of Formula V: R1-A1-Val-Aib-Glu-Ile-Gln-A7-A8-His-Gln-A11-A12-A13-Trp-Leu-A16-A17-R2 Wherein A1 is Ac5c or Ac6c; A7 is Leu or Phe; A8 is Met, Leu or Nle; A11 is Har or Arg; A12 is Ala or Arg; A13 is Lys or Glu; A16 is Asn or absent; A17 is Glu or Asp; Wherein there is a covalent linkage between A13 and A17. The PTH(1-17) analogues can be used to treat decreases in bone mass resulting from, osteoporosis, osteomyelitis, hypercalcemia, osteopenia, osteonecrosis, periodontal bone loss, osteolytic metastasis, dysplasias of bone and bone fractures.
Patent NZ-588461-A (NZ)
Title: Drainable ostomy pouch with a collection portion, a drain chute, fastener and a pocket
Inventor: MURRAY KIMBERLY
IPC: A61F5/445
Filed: 2009-04-07
Abstract: 588461 A drainable ostomy pouch includes a collection portion and a drain chute extending from the collection portion having a discharge opening for permitting emptying of contents from the pouch. The drain chute is foldable between an open condition in which the drain chute is extended from the collection portion, and a closed condition in which the drain chute is folded towards the collection portion; and a pocket for receiving at least a portion of the drain chute when the drain chute is in its closed condition.
Patent NZ-589685-A (NZ)
Title: Cushion for patient breathing interface with variable density foam supported membrane
Inventor: DAVIDSON AARON SAMUEL
IPC: A61M16/06
Filed: 2008-04-16
Abstract: A cushion 20 for a patient interface that delivers breathable gas to a patient includes a membrane 22 and a foam insert 25 constructed of foam and provided to the membrane to support the membrane. The foam insert is structured to provide a variable spring component to the membrane and includes different stiffnesses in different regions NB, CH, C by variation of the material properties, such as the density, of the foam. The cushion is particularly suitable for attachment to the mask frame of a full face mask.
Patent NZ-590009-A (NZ)
Title: Antineoplastic combinations containing hki-272 and vinorelbine
Inventor: ZACHARCHUK CHARLES
IPC: A61K31/4745
Filed: 2009-06-17
Abstract: Use of a vinorelbine compound (4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl- methyl ester, (2beta, 3beta, 4beta, 5alpha, 12R, 19alpha)-aspidospermidine-3-carboxylic acid) and a HKI-272 ((E)-N-{ 4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyI} -4-(dimethylamino)-2-butenamide) compound in the manufacture of a medicament for treating a neoplasm in a subject, wherein said neoplasm is selected from the group consisting of a lung cancer, breast cancer, myeloma, prostate cancer, head and neck cancer, transitional cell carcinoma, small cell neuroendocrine carcinoma of the uterine cervix, and large cell neuroendocrine carcinoma of the uterine cervix.
Patent NZ-592881-A (NZ)
Title: Quinolone compound and pharmaceutical composition
Inventor: OTSUBO KENJI
IPC: A61K31/4741
Filed: 2009-12-04
Abstract: Disclosed herein are quinolone compound represented by General Formula (1), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as a prophylactic and/or therapeutic agent for neurodegenerative diseases induced by neurological dysfunction or diseases induced by deterioration of mitochondrial function, such as Parkinson's disease, Parkinson's syndrome, juvenile parkinsonism, striatonigral degeneration, progressive supranuclear palsy, pure akinesia, Alzheimer's disease, Pick's disease, prion disease, corticobasal degeneration, diffuse Lewy body disease, Huntington's disease.
Patent NZ-594896-A (NZ)
Title: Biomarker for monitoring patients
Inventor: ACRES BRUCE
IPC: G01N33/50
Filed: 2010-04-12
Abstract: 594896 Biomarker for monitoring patients Provided is an ex-vivo method for predicting the clinical outcome in a patient after initiation of a treatment of said patient with an immunogenic composition containing at least one recombinant viral vector, wherein said patient received one or more doses of said immunogenic composition, said method comprising measuring the level of activated T lymphocytes CD3+ CD69+ in a blood sample from said patient after the patient received at least one dose of the said immunogenic composition, wherein the efficacy of the treatment is assessed based on the level of activated T lymphocytes above 10.4%.
Patent NZ-597007-A (NZ)
Title: Meningococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
Inventor: ROKBI BACHRA
IPC: A61K39/095
Filed: 2010-05-12
Abstract: 597007 Disclosed is a process for manufacturing a strain of Neisseria meningitidis bearing a lipooligosaccharide (LOS) formed from a lipid A, an inner core, and an ? chain of L6 type, in which the heptose II residue of the inner core bears a phosphoethanolamine (PEA) substituent in position O-3 and in position O-6 or O-7; wherein a N. meningitidis strain of immunotype L6 is modified such that it expresses the lpt3 gene. Further disclosed is a process for manufacturing a strain of Neisseria meningitidis bearing a lipooligosaccharide (LOS) formed from a lipid A, an inner core, and an ? chain of L6 type, in which the heptose II residue of the inner core bears a phosphoethanolamine (PEA) substituent in position O-3 and does not bear a PEA substituent in positions O-6 and O-7; wherein a N. meningitidis strain of immunotype L6 is modified such that it expresses the lpt3 gene and such that it no longer expresses the lpt6 gene. Further disclosed are the Neisseria meningitidis strains bearing said LOS and the LOS produced therefrom.
Patent NZ-601097-A (NZ)
Title: Insect resistance management with combinations of cry1be and cry1f proteins
Inventor: SHEETS JOEL J
IPC: A01P7/00
Filed: 2010-12-16
Abstract: Disclosed is a transgenic plant comprising DNA encoding a Cry1Be insecticidal protein and DNA encoding a Cry1Fa insecticidal protein. Also disclosed is a composition for controlling lepidopteran pests comprising non-human transgenic cells that express effective amounts of both a Cry1F insecticidal protein and a Cry1Be insecticidal protein. Further disclosed is a method of controlling an insect selected from the group consisting of a European corn borer and a fall armyworm, said method comprising contacting said insect with a Cry1Be insecticidal protein and a Cry1Fa insecticidal protein.
Patent NZ-603628-A (NZ)
Title: Container having side walls that can be folded over one another
Inventor: BARTH CHRISTIAN
IPC: B65D6/26
Filed: 2011-02-04
Abstract: A container 1 for transporting and storing goods with a container base 2 and at least two side walls 4 that can be folded over one another. The two side walls 4 that can be folded over one another are respectively pivotably supported through at least one hinge bolt 6 in a hinge bolt receiver 5. The hinge bolt receiver 5 includes an elongated recess 7, which extends in a direction perpendicular to the container base 2. The folded down side wall is movable from a lower end position, in which the folded down side wall 4 contacts the container base 2, into an upper end position, which is displaced upward from the lower end position in a direction perpendicular to the container base 2. The hinge bolt 6, by means of the cooperation of a lug 16 provided at the hinge bolt 6 and a ramp 14 formed in the recess 7, is provided with a guided translatoric movement when the side wall is folded up from the lower end position, so that the side wall 4 moves upward in a direction perpendicular to the container base 2. The recess 7 is tapered in downward direction and the tapered portion of the recess 7 defines the ramp 14 which forms a positive guide for the hinge bolt 6 when the side wall is folded up from the lower end position
Patent NZ-604745-A (NZ)
Title: Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
Inventor: KÜHNERT SVEN
IPC: A61K31/4709
Filed: 2011-08-26
Abstract: This disclosure relates to a family of 2 -oxy-quinoline-3-carboxamides of formula (I) with a varied amount of substitution off the quinoline frame. The frame is characterised by an aryl ether at the two position and an amide bond at the three position that can be substituted further. The disclosure also relates to pharmaceutical compositions containing these compounds and a method of treatment and/or prophylaxis of pain, epilepsy, urinary incontinence, anxiety, dependency, mania, bipolar disorders, migraine and cognitive diseases, which are all mediated, at least in part, by KCNQ2/3 K+ channels. Example compounds include: 2-ethoxy-4-methyl-N-(p-tolyl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxylic acid amide; 2-ethoxy-4-methyl-N-(4-methyl-pentyl)-7-(trifluoromethyl)-quinoline-3-carboxylic acid amide; 2-methoxy-4-methyl-N-(4-methyl-pentyl)-7-(trifluoromethyl)-quinoline-3-carboxylic acid amide; N-(4,4-dimethyl-pentyl)-2-methoxy-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxylic acid amide; N-(4,4-dimethyl-pentyl)-2-ethoxy-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxylic acid amide; 7-bromo-2-ethoxy-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxylic acid amide; 7-bromo-2-ethoxy-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxylic acid amide; 7-bromo-N-[(3-fluorophenyl)-methyl]-2-methoxy-4-methyl-quinoline-3-carboxylic acid amide; 7-bromo-N-[(4-fIuorophenyl)-methyl]-2-methoxy-4-methyl-quinoline-3-carboxylic acid amide; 7-cyano-2-ethoxy-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxylic acid amide; 7-cyano-2-ethoxy-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxylic acid amide; 7-cyano-N-[(3-fluorophenyl)-methyl]-2-methoxy-4-methyl-quinoline-3-carboxylic acid amide.
Patent NZ-608074-A (NZ)
Title: Thermatic torpedo for reinstatement materials
Inventor: WRIGHT JAMES
IPC: E01C19/46
Filed: 2011-10-16
Abstract: A thermatic torpedo (10) for preparing and delivering reinstatement such as asphalt materials is disclosed. The torpedo comprises an internal chamber defining at least one compartment (20) for containing graded aggregate and a second compartment (21) for containing a stabilising agent. An external skin (11) is provided for insulating the contents of the internal chamber and a cap or lid secures the contents. A telescopic probe can be driven through the compartments (20, 21, 22) to heat and/or mix the contents in use and a plunger can be used to expel the materials from the chamber. The aggregate materials and stabilising agent are preloaded into discreet capsules which are inserted into the torpedo (10). A method of delivering aggregate and stabilising agent using such a torpedo (10) is also disclosed.
Patent NZ-611133-A (NZ)
Title: Systems and methods for lottery-style games
Inventor: OAKES JAMES ALLAN
IPC: G07F17/32
Filed: 2008-07-25
Abstract: Disclosed is a computer-implemented method for lottery-style games. The method includes: establishing an online game that is scheduled to have lottery drawings on a number of drawing days, each lottery drawing to take place on one drawing day; and accepting enrolment of a plurality of players in the online game. Each player is assigned at least one unique identifier and is committed to participate in a plurality of the lottery drawings. The method also includes receiving, from each player, a designated number of tokens to be entered for each of the at least one unique identifier in each of the plurality of the lottery drawings said player is committed to participate in. Each designated number is at least one and up to a predetermined maximum. The method further includes executing the online game by doing the following on each drawing day: pooling tokens entered for said drawing by players participating on said drawing day, together with tokens carried over from one or more previous drawing days, if any, to form a jackpot for said drawing day; conducting a drawing, from unique identifiers of the players participating on said drawing day, to select one winner; and calculating a proportional value based on: (a) the designated number of tokens the selected winner has entered for said drawing; and (b) the predetermined maximum, and providing a fraction of the jackpot to the selected winner based on the calculated proportional value.
Patent NZ-613240-A (NZ)
Title: Injectable antibiotic formulations and their methods of use
Inventor: IAN GEORGE TUCKER
IPC: A61P31/00
Filed: 2012-07-17
Abstract: Disclosed is a composition including penethamate (PNT) which is also known as penethacillin; (6α-[(Phenylacetyl)amino]penicillanic acid 2-(diethylamino)ethyl) ester; or (2S,5β)-3,3-Dimethyl-7-oxo-6α-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2β-carboxylic acid 2-(diethylamino)ethyl ester or a pharmaceutical equivalent thereof; and triacetin which is also known as 1,2,3-triacetoxypropane, glycerin triacetate or 1,3-Diacetyloxypropan-2-yl acetate. PNT is the diethylaminoethyl ester of benzylpenicillin. Also disclosed is the method of treating an animal suffering form a microbial infection by administering the composition. Further disclosed is the method for manufacturing the composition.
Patent NZ-613264-A (NZ)
Title: Use of vitamin k for weight maintenance and weight control
Inventor: VERMEER CEES
IPC: A23L33/15
Filed: 2011-12-19
Abstract: Disclosed is a non-therapeutic method for weight reduction in an overweight or obese subject wherein an effective amount of vitamin K is administered to the subject to increase the vitamin K status in the subject. Also disclosed is the use of a pharmaceutical formulation comprising an effective amount of vitamin K in the manufacture of a medicament for the treatment or prevention of overweight in an overweight or obese subject, with the proviso that said medicament does not contain an essential fatty acid (EFA).
Patent NZ-615329-A (NZ)
Title: A ventilator comprising a blower and a valve assembly
Inventor: CHALVIGNAC PHILIPPE AUGUSTE
IPC: F04D29/66
Filed: 2010-08-11
Abstract: Disclosed is a ventilator (10). The ventilator (10) includes a blower structured to provide a source of pressurized air and a valve assembly provided to the blower and structured to allow air to flow through the blower along a flow path in both directions. The blower includes a flow element along the flow path structured to measure flow in both directions and conduct heat from a motor of the blower.
Patent NZ-617390-A (NZ)
Title: A method for determining structural parameters of composite building panels
Inventor: LI ALFRED
IPC: E04C2/04
Filed: 2012-04-02
Abstract: A method of determining face paper properties of wallboard such gypsum plasterboard from a core strength value of the wallboard to achieve a required nail pull value is disclosed. A face paper stiffness value is calculated using a processor from a formula based on the provided core strength value, board density and the required nail pull value. The calculated face paper stiffness value is displayed and the wall board is manufactured using the selected face paper type. The method allows the pull strength to be predicted prior to manufacture to select the most appropriate face paper without waste of time and materials.
Patent NZ-618248-A (NZ)
Title: Use of isoxazoline compounds as anti-parasitic agents
Inventor: LAHM GEORGE PHILIP
IPC: C07D261/04
Filed: 2008-06-26
Abstract: Disclosed is method for protecting a non-human mammal such as livestock, a canine (including dogs), a feline (including cats) from fleas, by administered orally or parenterally a compound of Formula 1, which is fluralaner (4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl-N-[(N-(2,2,2-trifluoroethyl)carbamoyl)methyl]benzamide / 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl-N-[N-(2,2,2-trifluoroethyl)carbamoyl methyl]benzoic acid amide / 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]benzamide), an N-oxide or a salt thereof. Preferably, the compound is administered such that the mammal is protected for 24 hours after oral, parenteral administration or injection. It is also disclosed that fluralaner is to be administered orally or parenterally about daily to yearly, about weekly to about once every six months, and preferably monthly.
Patent NZ-620688-A (NZ)
Title: Use and agrochemical composition of carboxylic acid dibutylamides
Inventor: AULER THOMAS
IPC: A01P13/00
Filed: 2012-08-10
Abstract: Disclosed is the use of N,N-dibutylcarboxamides of formula (I): R1-CO-NR2-R3 in agrochemical formulations as a tank mix additive for promoting the penetration of active agrochemical ingredients into plants, wherein R1 is C16-C18-alkyl or C16-C18-alkeny and R2 and R3 are C4-alkyl. Also disclosed is an agrochemical formulation in the form of an emulsion concentrate or dispersion oil comprising a C16-C18-carboxylic acid dibutylamide and at least one active agrochemical ingredient which is solid at room temperature is selected from the group consisting of cyproconazole, epoxiconazole, metconazole, propiconazole, prothioconazole, tebuconazole, azoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, picoxystrobin, pyraclostrobin, trifloxystrobin, isopyrazam, indaziflam, fluopyram, fluxapyroxad, bixafen, amidosulfuron, bromoxynil, cyprosulfamide, 2,4-D, glufosinate, glyphosate, iodosulfuron-methyl, isoxadifenethyl, mefenpyr, mesosulfuron, mesotrione, metamitron, phenmedipham, sulcotrione, tembotrione and thiencarbazone-methyl.
Patent NZ-625659-A (NZ)
Title: Roller door
Inventor: BRUNTON MARK JAMES
IPC: E06B9/15
Filed: 2013-05-29
Abstract: Disclosed is a roller door having a plurality of horizontal slats (13) being held together by one or more substantially vertical and flexible elongate members (15). The plurality of horizontal slats are connected at an upper end to an accumulation device, such as a roller drum (see 23, figure 2). Each of the horizontal slats consists primarily of a foamed plastics material. Contact between adjacent horizontal slats comprises direct contact between the foamed plastics material of each adjacent horizontal slat (see figure 6).
Patent NZ-707871-A (NZ)
Title: A method for manufacturing biodegradable packaging material, biodegradable packaging material and a package or a container made thereof
Inventor: NEVALAINEN KIMMO
IPC: D21H19/28
Filed: 2013-10-28
Abstract: The invention provides a biodegradable packaging materi- al, a method of manufacturing the same, as well as products made of the material. The manufacture comprises extrusion onto a fibrous substrate (1) one or more polymer coating layers including at least one layer (2) of a polymer blend consisting of (i) 20-95 wt-% of polylactide having a high melt index of more than 35 g/10 min (210 °C; 2.16 kg), (ii) 5-80 wt-% of polybutylene succinate (PBS) or a biodegradable derivate thereof, and (iii) 0-5 wt-% of one or more polymeric additives. The components of the blend are melted and blended in connection with the extrusion step. The goal is to improve extrudability, increase ma- chine speed in extrusion and maintaining good adhesive- ness to the substrate and good heat-sealability of the coat- ing. The products include disposable drinking cups and board trays, as well as sealed carton packages for solids and liquids.
Patent NZ-711167-A (NZ)
Title: An actuator pin incorporating a lateral stabilizer
Inventor: RAIHALA DANIEL J
IPC: B02C1/02
Filed: 2014-02-18
Abstract: There is a need for an alternative means of laterally stabilizing the upper jaw of a demolition shear attachment where the lateral stabilizer is not mounted within the main body of the shear attachment. The present invention relates to a demolition shear. The demolition shear comprises a main body having a forward end and a rearward end, said forward end of said main body including a lower jaw. The demolition shear further comprises an upper jaw pivotally supported by a jaw pivot pin at said forward end of said main body. The demolition shear further comprises an actuator having a clevis end pivotally attached to said upper jaw by an actuator pin assembly, said actuator adapted to pivotally move said upper jaw about said jaw pivot pin between an open position and a closed position, said pivotal movement of said upper jaw defining an arcuate path of said actuator pin assembly. Said actuator pin assembly comprises a pin having a head, said head having an outer periphery configured to be receivable within a complimentary configured keeper attached to one side of said clevis end of said actuator such that said head is rotationally fixed with respect to said keeper. Said actuator pin assembly further comprises a pin cap adapted to secure to a distal end of said pin, said pin cap having an outer periphery configured to be receivable within a complimentary configured keeper attached to another side of said clevis end of said actuator such that said pin cap is rotationally fixed with respect to said keeper. Said actuator pin assembly further comprises a wear plate received within said head, said wear plate disposed to bear against a wear surface of said main body as said wear plate moves along at least a portion of said arcuate path so as to laterally restrain said upper jaw from lateral translation as said upper jaw pivots between said open position toward said closed position during shearing operations.